by October Gallery
FILE PHOTO: A health worker fills a syringe with Ebola vaccine before injecting it to a patient, in Goma, Democratic Republic of Congo, August 5, 2019. REUTERS/Baz Ratner/File Photo (Reuters)…
FILE PHOTO: Bottles of drugs sit on the shelf at the Rock Canyon Pharmacy, in Provo, Utah, U.S., May 9, 2019. REUTERS/GEORGE FREY (Reuters) – The Trump administration is appealing…
(Reuters) – Teva Pharmaceutical Industries Ltd on Tuesday made its generic version of Mylan’s EpiPen for young children available in most retail pharmacies at $300 for a 2-pack. EpiPen auto-injection…
(Reuters) – Drug distributor Cardinal Health Inc (CAH.N) warned on Tuesday that its business could be hurt as it defends itself against several opioid-related lawsuits. Several pharmaceutical wholesale distributors, including…
(Reuters) – Sarepta Therapeutics Inc said on Monday the U.S. Food and Drug Administration declined to approve its newest treatment for Duchenne muscular dystrophy (DMD), citing safety concerns including the…
FILE PHOTO: The logo of Swiss pharmaceutical company Roche is seen outside the Shanghai Roche Pharmaceutical Co. Ltd. headquarters in Shanghai May 22, 2014. REUTERS/Aly Song (Reuters) – The U.S.…
(Reuters Health) – Surgeons are no better at determining which patients might benefit from operations to treat torn knee cartilage than if they just flipped a coin, a new study…
(Reuters Health) – Less than 10% of U.S. stroke patients get a treatment that evidence shows is most effective for a certain type of stroke – and the odds are…
FILE PHOTO: The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland February 1, 2018. REUTERS/Arnd Wiegmann (Reuters) – Roche Holding AG has priced its personalized…
(Reuters) – AbbVie Inc has priced its new rheumatoid arthritis treatment at $59,000 a year after gaining U.S. approval on Friday, a big boost for the drugmaker struggling with rising…